Literature DB >> 27979577

Vitamin D measurement standardization: The way out of the chaos.

N Binkley1, B Dawson-Hughes2, R Durazo-Arvizu3, M Thamm4, L Tian5, J M Merkel6, J C Jones7, G D Carter7, C T Sempos8.   

Abstract

Substantial variability is associated with laboratory measurement of serum total 25-hydroxyvitamin D [25(OH)D]. The resulting chaos impedes development of consensus 25(OH)D values to define stages of vitamin D status. As resolving this situation requires standardized measurement of 25(OH)D, the Vitamin D Standardization Program (VDSP) developed methodology to standardize 25(OH)D measurement to the gold standard reference measurement procedures of NIST, Ghent University and CDC. Importantly, VDSP developed protocols for standardizing 25(OH)D values from prior research based on availability of stored serum samples. The effect of such retrospective standardization on prevalence of "low" vitamin D status in national studies reported here for The Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994) and the German Health Interview and Examination Survey for Children and Adolescents (KIGGS, 2003-2006) was such that in NHANES III 25(OH)D values were lower than original values while higher in KIGGS. In NHANES III the percentage with values below 30, 50 and 75 nmol/L increased from 4% to 6%, 22% to 31% and 55% to 71%, respectively. Whereas in KIGGS after standardization the percentage below 30, 50, and 70 nmol/L decreased from 28% to 13%, 64% to 47% and 87% to 85% respectively. Moreover, in a hypothetical example, depending on whether the 25(OH)D assay was positively or negatively biased by 12%, the 25(OH)D concentration which maximally suppressed PTH could vary from 20 to 35ng/mL. These examples underscore the challenges (perhaps impossibility) of developing vitamin D guidelines using unstandardized 25(OH)D data. Retrospective 25(OH)D standardization can be applied to old studies where stored serum samples exist. As a way forward, we suggest an international effort to identify key prior studies with stored samples for re-analysis and standardization initially to define the 25(OH)D level associated with vitamin D deficiency (rickets/osteomalacia). Subsequent work could focus on defining inadequacy. Finally, examples reported here highlight the importance of suspending publication of meta-analyses based on unstandardized 25(OH)D results. Published by Elsevier Ltd.

Entities:  

Keywords:  25-Hydroxyvitamin D; CAP; DEQAS; NIST; PT/EQA; Vdsp; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27979577     DOI: 10.1016/j.jsbmb.2016.12.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  48 in total

Review 1.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

Review 2.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Authors:  Christopher T Sempos; Annemieke C Heijboer; Daniel D Bikle; Jens Bollerslev; Roger Bouillon; Patsy M Brannon; Hector F DeLuca; Glenville Jones; Craig F Munns; John P Bilezikian; Andrea Giustina; Neil Binkley
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

Review 3.  Dietary Vitamin D Intake for the Elderly Population: Update on the Recommended Dietary Allowance for Vitamin D.

Authors:  Lynette M Smith; J Christopher Gallagher
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

4.  Cost effective measures to standardize serum 25(OH)D values from completed studies.

Authors:  C T Sempos; R A Durazo-Arvizu; G D Carter
Journal:  Osteoporos Int       Date:  2017-03-20       Impact factor: 4.507

5.  Variable Thresholds of Vitamin D Plasma Levels to Suppress PTH: the Effect of Weight and Bariatric Surgery.

Authors:  Daniela Alves Salazar; Maria João Silva Ferreira; João Sérgio Neves; Jorge Manuel Pires Pedro; Vanessa Alexandra Guerreiro; Sara E Silva Viana; Fernando Mendonça; Maria Manuel Silva; Sandra Patrícia Belo; Ana Varela Sande; Paula Freitas; David Maurício Carvalho
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

Review 6.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

7.  Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease.

Authors:  Kathleen E Altemose; Juhi Kumar; Anthony A Portale; Bradley A Warady; Susan L Furth; Jeffrey J Fadrowski; Meredith A Atkinson
Journal:  Pediatr Nephrol       Date:  2018-07-14       Impact factor: 3.714

Review 8.  Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors.

Authors:  Lillian Sun; Joshua Arbesman; Melissa Piliang
Journal:  Arch Dermatol Res       Date:  2020-06-09       Impact factor: 3.017

9.  Measurement of Vitamin D for Epidemiologic and Clinical Research: Shining Light on a Complex Decision.

Authors:  Anne Marie Z Jukic; Andrew N Hoofnagle; Pamela L Lutsey
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

10.  Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment.

Authors:  Heike Luttmann-Gibson; Samia Mora; Carlos A Camargo; Nancy R Cook; Olga V Demler; Amit Ghoshal; Jay Wohlgemuth; Kris Kulkarni; Julia Larsen; James Prentice; Michael Cobble; Vadim Bubes; Chunying Li; Georgina Friedenberg; I-Min Lee; Julie E Buring; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2019-10-24       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.